| HOME >> BIOLOGY >> TECHNOLOGY |
ANTONY, France, October 15 /PRNewswire-FirstCall/ --
(EUR millions) 2007 07/06 2008 08/07
EUR % % EUR % %
millions sales change millions sales change
Southern Europe (1) 20.6 71 17 23.8 70 16
Other EU countries (2) 7.1 24 17 8.6 25 21
Other markets 1.5 5 24 1.8 5 18
SLIT 22.1 76 22 26.3 77 19
SCIT 6.0 20 6 6.5 19 8
Other products 1.1 4 (4) 1.4 4 27
Total Q3 sales 29.2 100 17 34.2 100 17
Southern Europe (1) 77.2 74 17 88.6 74 15
Other EU countries (2) 22.8 22 15 27.2 22 19
Other markets 4.0 4 12 5.5 4 36
SLIT 81.9 79 21 97.6 81 19
SCIT 17.8 17 3 18.8 15 6
Other products 4.4 4 1 4.8 4 11
Cumulative 9-month sales 104.0 100 17 121.2 100 17
(1) Portugal, Spain, France, Italy, Greece;
(2) Switzerland included
Sales growth and financial position
2008 third quarter sales continued to strongly increase with double digit growth in all regions, in a market primarily driven by the sublingual route (+21% in Q3, vs. +8% for the sub-cutaneous route). Cumulative 9-month sales at end September grew by 17%, the same growth rate as in 2007.
Net borrowings registered a 5% year-on-year decline at end September,
confirming the Company's strong financial position, and only represented
16% of equity.
<
'/>"/>
| SOURCE Stallergenes Copyright©2008 PR Newswire. All rights reserved |